West Pharmaceutical Services, Inc. (NYSE: WST) reported fourth-quarter 2025 financial results on Thursday that exceeded analyst expectations, supported by strong…
Medpace Holdings, Inc. (NASDAQ: MEDP) delivered a strong fourth quarter with significant top-line and bottom-line growth, beating analyst estimates. However,…